Inmune Bio, Inc. Sales Agreements
4 Contracts & Agreements
- Amendment No. 1 to At-the-Market Sales Agreement, dated August 16, 2023, between INmune Bio Inc., and BTIG, LLC (Filed With SEC on August 16, 2023)
- At-The-Market Sales Agreement, dated March 10, 2021, between the Company and BTIG (Filed With SEC on March 11, 2021)
- Amendment No. 1 to At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG (Filed With SEC on August 19, 2020)
- At-The-Market Sales Agreement, dated April 16, 2020, between the Company and BTIG (Filed With SEC on April 17, 2020)
